Replies to post #188571 on Biotech Values

[DewDiligence]

PPHM—I give it a 50/50 that in the next year something comes out from them hinting at checkpoint activity…

It already happened; from PPHM’s Dec 2014 CC:

http://seekingalpha.com/article/2748275-peregrine-pharmaceuticals-pphm-ceo-steven-king-on-q2-2015-results-earnings-call-transcript?all=true

Bavi goes after an upstream checkpoint, whereas PD-1 and CTLA-4 are downstream checkpoints.

[honestabe13]

iwfal..

considering the third party in the messy P2 trial acknowledged that one of their employees switched placebo and drug doses, as is on record in the ongoing lawsuit filings, give the clinical tirals critique a rest.

as far as the immuno claims about pphm's compound, if the science backs it up, why is it laughable? PPHM acknowledged years ago they didn't fully understand the MOA, and now they do. they were being intellectually honest, which some here are not.

for a bunch of so-called experts here, it seems poking fun at your favorite targets trumps discussing current verified clinical discoveries.

[jq1234]

You forgot angiogenesis MOA. Next Avastin LOL!